This inventor holds 3 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignee: Salix Pharmaceuticals, Inc.. Active years: 2010-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2013
Title: The Innovations of Stephen Skiendzielewski
Introduction
Stephen Skiendzielewski is an accomplished inventor based in Norristown, PA (US). He holds a total of 3 patents that reflect his contributions to the field of medical innovations. His work primarily focuses on improving patient care and compliance through novel formulations.
Latest Patents
One of his latest patents is a colonic purgative composition with a soluble binding agent. This invention relates to novel colonic purgative compositions in a solid dosage form, comprising at least one purgative and at least one soluble, or soluble, nonfermentable binder, such as polyethylene glycol. The invention also includes methods of using these colonic purgative compositions. The present compositions and methods are designed to improve patient tolerance and compliance, while simultaneously enhancing the quality of bowel cleansing. These formulations are particularly useful for cleansing the bowel prior to diagnostic and surgical procedures and can also be employed in lower dosages as a laxative to promote elimination and relieve constipation.
Career Highlights
Throughout his career, Stephen has worked with notable companies, including Salix Pharmaceuticals, Inc. His experience in the pharmaceutical industry has allowed him to develop innovative solutions that address critical healthcare needs.
Collaborations
Stephen has collaborated with professionals such as Martin Rose and Ngoc Do, contributing to the advancement of medical technologies and patient care.
Conclusion
Stephen Skiendzielewski's work exemplifies the impact of innovation in the medical field. His patents and collaborations highlight his commitment to improving patient outcomes through effective and novel solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
